Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 18 studies | 24% ± 8% | |
mast cell | 12 studies | 25% ± 8% | |
non-classical monocyte | 9 studies | 34% ± 18% | |
memory B cell | 8 studies | 21% ± 4% | |
naive B cell | 8 studies | 23% ± 8% | |
classical monocyte | 6 studies | 27% ± 16% | |
endothelial cell | 6 studies | 32% ± 14% | |
hematopoietic precursor cell | 5 studies | 34% ± 18% | |
platelet | 5 studies | 28% ± 7% | |
erythrocyte | 5 studies | 29% ± 9% | |
hematopoietic stem cell | 4 studies | 25% ± 11% | |
microglial cell | 4 studies | 28% ± 5% | |
macrophage | 4 studies | 20% ± 4% | |
conventional dendritic cell | 3 studies | 29% ± 11% | |
endothelial cell of artery | 3 studies | 26% ± 8% | |
immature B cell | 3 studies | 26% ± 7% | |
monocyte | 3 studies | 24% ± 6% | |
granulocyte | 3 studies | 40% ± 7% | |
granulocyte monocyte progenitor cell | 3 studies | 22% ± 5% | |
megakaryocyte | 3 studies | 43% ± 9% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 55% ± 17% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 26% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 95% | 388.13 | 622 / 653 | 92% | 6.41 | 554 / 605 |
lung | 99% | 881.03 | 573 / 578 | 87% | 5.07 | 1000 / 1155 |
breast | 99% | 504.31 | 454 / 459 | 82% | 4.68 | 920 / 1118 |
uterus | 100% | 552.51 | 170 / 170 | 81% | 4.19 | 372 / 459 |
kidney | 93% | 327.75 | 83 / 89 | 86% | 6.06 | 771 / 901 |
bladder | 100% | 539.52 | 21 / 21 | 76% | 4.62 | 384 / 504 |
intestine | 99% | 528.20 | 955 / 966 | 73% | 3.64 | 387 / 527 |
prostate | 98% | 407.03 | 239 / 245 | 70% | 2.70 | 351 / 502 |
adrenal gland | 93% | 262.52 | 239 / 258 | 74% | 4.77 | 171 / 230 |
ovary | 74% | 167.17 | 133 / 180 | 87% | 4.45 | 376 / 430 |
brain | 64% | 165.86 | 1695 / 2642 | 97% | 8.84 | 681 / 705 |
stomach | 78% | 213.51 | 279 / 359 | 79% | 4.98 | 227 / 286 |
esophagus | 89% | 308.65 | 1282 / 1445 | 67% | 2.77 | 122 / 183 |
skin | 58% | 130.38 | 1044 / 1809 | 90% | 7.42 | 424 / 472 |
pancreas | 17% | 33.96 | 56 / 328 | 93% | 7.55 | 165 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 74.38 | 29 / 29 |
peripheral blood | 100% | 5670.40 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 2400.25 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.67 | 1 / 1 |
adipose | 99% | 646.81 | 1194 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 364.04 | 840 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 4.67 | 76 / 80 |
blood vessel | 95% | 370.52 | 1262 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 6.71 | 39 / 45 |
liver | 25% | 52.14 | 57 / 226 | 56% | 2.64 | 228 / 406 |
muscle | 27% | 45.44 | 220 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030183 | Biological process | B cell differentiation |
GO_0060216 | Biological process | definitive hemopoiesis |
GO_0001955 | Biological process | blood vessel maturation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | LYL1 |
Protein name | Protein lyl-1 (Class A basic helix-loop-helix protein 18) (bHLHa18) (Lymphoblastic leukemia-derived sequence 1) LYL1 basic helix-loop-helix family member |
Synonyms | BHLHA18 |
Description | |
Accessions | ENST00000590974.1 P12980 K7ER61 ENST00000264824.5 |